Terms ending in 2032
Every in-force patent on Respivert Limited's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,108,950 | 1-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- 1- Yl) Ureas as P38 Map Kinase Inhibitors In force · High confidence | Respivert Limited | In force | High confidence | |
| US 9,475,796 | 1-Pyrazolyl-3-((4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · High confidence | Respivert Limited | In force | High confidence | |
| US 9,724,347 | 1-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · High confidence | Respivert Ltd. | In force | High confidence | |
| US 9,850,231 | 1-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors In force · Low confidence | Respivert Limited | In force | Low confidence | |
| US 9,993,478 | 1-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · Medium confidence | Respivert Ltd. | In force | Medium confidence | |
| US 10,238,658 | 1-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · Medium confidence | Respivert Limited | In force | Medium confidence | |
| US 10,266,519 | 1-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors In force · Low confidence | Respivert Limited | In force | Low confidence | |
| US 10,738,032 | 1-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors In force · Low confidence | Respivert Limited | In force | Low confidence | |
| US 10,813,932 | 1-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors In force · Medium confidence | Respivert Limited | In force | Medium confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.